Compare RDHL & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDHL | FGI |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3M | 16.0M |
| IPO Year | 2012 | 2021 |
| Metric | RDHL | FGI |
|---|---|---|
| Price | $0.48 | $8.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 209.2K | 39.9K |
| Earning Date | 09-30-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | N/A | N/A |
| Revenue This Year | $17,592.31 | $3.45 |
| Revenue Next Year | $25.89 | $5.39 |
| P/E Ratio | ★ N/A | $45.12 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $3.14 |
| 52 Week High | $2.26 | $19.93 |
| Indicator | RDHL | FGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.08 | 49.78 |
| Support Level | N/A | $6.63 |
| Resistance Level | $1.07 | $10.30 |
| Average True Range (ATR) | 0.03 | 0.82 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 12.97 | 18.64 |
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, it generates the majority of its revenue from the United States, followed by Canada and Europe.